about
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approachIntravenous immunoglobulin to prevent relapses during pregnancy and postpartum in multiple sclerosisEpigenetic Drugs for Multiple SclerosisMindfulness-based interventions in multiple sclerosis: beneficial effects of Tai Chi on balance, coordination, fatigue and depression.Experiences of hospitalization in patients with multiple sclerosis: A qualitative studyCladribine tablets: in relapsing-remitting multiple sclerosis.Molecular analysis of interleukin-25 exons 1 and 2 and its serum levels in Iranian patients with multiple sclerosis.Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosis.Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tabletsImpact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up studyThe MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosis'You are just left to get on with it': qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis.Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis Patients.Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosisDisease-modifying drugs for multiple sclerosis: current and future aspects.Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosisPersonal identity and the role of 'carer' among relatives and friends of people with multiple sclerosisPatient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment.The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' Experiences.Meeting the needs of people with primary progressive multiple sclerosis, their families, and the health-care community.Perceived met and unmet health-care needs in a community population with multiple sclerosis.Affective Temperament Profiles in Patients with Multiple Sclerosis: Association with Mood Disorders.Cannabinoids, multiple sclerosis and neuroprotection.Emerging oral drugs for relapsing-remitting multiple sclerosis.Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis.Cost-effectiveness analysis of ocrelizumab versus subcutaneous interferon beta-1a for the treatment of relapsing multiple sclerosis.Depression in multiple sclerosis.The effect of high-dose steroid treatment used for the treatment of acute demyelinating diseases on endothelial and cardiac functions.How do carers of people with multiple sclerosis engage with websites containing the personal experiences of other carers and patients?Simulation of spread and control of lesions in brainDiagnosis and treatment of multiple sclerosis: potential changes in management for clinically isolated episode of optic neuritis.Diagnosis and treatment of multiple sclerosis: ocular manifestations of multiple sclerosis.Coping and its importance for quality of life in patients with multiple sclerosis.Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.Disability in a community population with MS with and without mental disorders.Advances in noninvasive myelin imaging.Anti lingo 1 (opicinumab) a new monoclonal antibody tested in relapsing remitting multiple sclerosis.
P2860
Q22305854-F13997F5-A123-429F-81FD-507F6C05657CQ24201599-F39DA462-8F8E-4ACE-AB25-4C5C083EA61FQ28076395-8AE46D00-7F99-4B03-B78E-AF4328BC9F4FQ30599387-2563E4E4-06CC-49E3-91E7-9F34108ECA15Q33771299-F401B091-25BF-4AF1-8EF4-BE2D4AA3A5DDQ33821160-A172E888-615D-4F33-84BA-601F176EB619Q34066491-BB24B87B-E04F-4E92-AA78-2CD1792DE84FQ34100842-D0B4E941-E84B-4A26-98A7-9D07095A8A42Q34133316-B1FBB098-1385-46F3-B74A-7A4A670BE51CQ34565669-2FA2C373-3BA5-4222-9EBF-6404D36DDAAFQ35674845-6396F948-288A-42E0-9668-D17852F5D120Q35884995-46C8E5A4-B33B-4132-81E6-E8D4FFC30042Q36181056-20DDD037-F2D5-4006-9622-C938B0A18B7DQ36213007-F803284B-F833-410B-AF2B-5E9882E3DD0EQ36582315-3D590E23-8627-457C-9030-4CA82996D314Q36613906-3CD04FE2-D56F-4792-B832-593BEB77FC89Q36664563-3292A37D-DDCE-4FC0-998A-4BF3B1427273Q37052797-E496AA8B-7914-4D28-9495-9A3B9601457EQ37186210-FC424DCF-C923-4199-BA32-5E6CB55C76C4Q37301353-D2094848-18B2-4072-947B-83805FCB0072Q37381139-2D6802C9-BAA8-40B7-B853-9A8D7B79DE55Q37442084-685B5B9D-717D-44DC-837D-D40ED8920257Q37442155-5C843536-E6F0-47CE-9211-A6DC7604CC13Q37703748-11C7033B-6C70-4B12-9E4B-20BDAA61BB58Q37960199-42E77F2A-920A-4A2B-A9DD-2C40461E3523Q37965547-1AF65A66-C115-4C94-B360-7449C487DE4EQ38121632-290FB94A-56B6-4F3B-AE6A-EE1C80912FC5Q38202636-B9BA4099-D561-46AB-A890-D78B11813EAEQ38681227-864D6001-417F-448A-B292-C1A4F802F9CAQ38691568-6B95AC22-29D0-4F28-B23C-B979F42642C7Q38783153-6B5D7567-5C57-4342-B7CE-E369FF584CB3Q40439524-93AD7377-254B-488C-871F-DB64FEA57794Q40882468-3B1634FB-A699-453B-866C-AD241EBDB276Q42996353-1FEED1B8-9FD7-4B61-AB6A-409EF78FE0F3Q43242398-81ED01DC-EBA2-40C8-AFEB-A4A744D7A0D0Q44412190-4EE63529-DAD9-40C2-9A6F-517FEA5F030BQ47158177-17750583-FC5C-4D53-918A-1937BDB0C810Q47699652-C7025FD5-5C70-4FD6-90EB-F5B3BE0591D3Q47821444-B4A9F9CF-D1C1-4968-BB6A-7B20E723A0C0Q47958350-D66084F8-2D7C-4C3D-82A6-E665201954AA
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Diagnosis and treatment of multiple sclerosis.
@ast
Diagnosis and treatment of multiple sclerosis.
@en
Diagnosis and treatment of multiple sclerosis.
@nl
type
label
Diagnosis and treatment of multiple sclerosis.
@ast
Diagnosis and treatment of multiple sclerosis.
@en
Diagnosis and treatment of multiple sclerosis.
@nl
prefLabel
Diagnosis and treatment of multiple sclerosis.
@ast
Diagnosis and treatment of multiple sclerosis.
@en
Diagnosis and treatment of multiple sclerosis.
@nl
P2860
P356
P1433
P1476
Diagnosis and treatment of multiple sclerosis.
@en
P2093
T J Murray
P2860
P304
P356
10.1136/BMJ.332.7540.525
P407
P577
2006-03-01T00:00:00Z